Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index
Jie Bai,1 Rui-Hui Wang,1 Yan Qiao,2 Aidong Wang,3 Chen-Jie Fang1 1Department of Chemical Biology, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 2Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, 3Department of Pharmaceu...
שמור ב:
Main Authors: | Bai J (Author), Wang RH (Author), Qiao Y (Author), Wang A (Author), Fang CJ (Author) |
---|---|
פורמט: | ספר |
יצא לאור: |
Dove Medical Press,
2017-07-01T00:00:00Z.
|
נושאים: | |
גישה מקוונת: | Connect to this object online. |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
פריטים דומים
-
Gibberellin derivative GA-13315 overcomes multidrug resistance in breast cancer by up-regulating BMP6 expression
מאת: Xianqiang Luo, et al.
יצא לאור: (2022) -
Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems
מאת: Mohammad Imran, et al.
יצא לאור: (2022) -
Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance
מאת: Xue Han, et al.
יצא לאור: (2019) -
Synthesis and cytotoxicity evaluation of thiosemicarbazones and their thiazole derivatives
מאת: Saulo Feheiberg Pinto Braga, et al. -
Genetic Variation Putatively Associated with <i>Mycobacterium tuberculosis</i> Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis
מאת: Igor Mokrousov, et al.
יצא לאור: (2020)